133L | A:1-130 | ROLE OF ARG 115 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME. X-RAY STRUCTURE OF HIS 115 AND GLU 115 MUTANTS |
134L | A:1-130 | ROLE OF ARG 115 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME. X-RAY STRUCTURE OF HIS 115 AND GLU 115 MUTANTS |
1A4V | A:1-123 | ALPHA-LACTALBUMIN |
1B5U | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANT |
1B5V | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS |
1B5W | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS |
1B5X | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS |
1B5Y | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS |
1B5Z | A:1-130; B:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS |
1B7L | A:1-130 | VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES |
1B7M | A:1-130 | VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES |
1B7N | A:1-130 | VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES |
1B7O | A:1-130 | VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES |
1B7P | A:1-130 | VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES |
1B7Q | A:1-130 | VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES |
1B7R | A:1-130 | VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES |
1B7S | A:1-130 | VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES |
1B9O | A:1-123 | HUMAN ALPHA-LACTALBUMIN, LOW TEMPERATURE FORM |
1BB3 | A:1-130; B:1-130 | HUMAN LYSOZYME MUTANT A96L |
1BB4 | A:1-130; B:1-130 | HUMAN LYSOZYME DOUBLE MUTANT A96L, W109H |
1BB5 | A:1-130; B:1-130 | HUMAN LYSOZYME MUTANT A96L COMPLEXED WITH CHITOTRIOSE |
1BVK | C:1-129; F:1-129 | HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME |
1C43 | A:1-130 | MUTANT HUMAN LYSOZYME WITH FOREIGN N-TERMINAL RESIDUES |
1C45 | A:1-130 | MUTANT HUMAN LYSOZYME WITH FOREIGN N-TERMINAL RESIDUES |
1C46 | A:0-130 | MUTANT HUMAN LYSOZYME WITH FOREIGN N-TERMINAL RESIDUES |
1C7P | A:-3-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME WITH FOUR EXTRA RESIDUES (EAEA) AT THE N-TERMINAL |
1CJ6 | A:1-130 | T11A MUTANT HUMAN LYSOZYME |
1CJ7 | A:1-130 | T11V MUTANT HUMAN LYSOZYME |
1CJ8 | A:1-130 | T40A MUTANT HUMAN LYSOZYME |
1CJ9 | A:1-130 | T40V MUTANT HUMAN LYSOZYME |
1CKC | A:1-130 | T43A MUTANT HUMAN LYSOZYME |
1CKD | A:1-130 | T43V MUTANT HUMAN LYSOZYME |
1CKF | A:1-130 | T52A MUTANT HUMAN LYSOZYME |
1CKG | A:1-130; B:1-130 | T52V MUTANT HUMAN LYSOZYME |
1CKH | A:1-130 | T70V MUTANT HUMAN LYSOZYME |
1D6P | A:1-130 | HUMAN LYSOZYME L63 MUTANT LABELLED WITH 2',3'-EPOXYPROPYL N,N'-DIACETYLCHITOBIOSE |
1D6Q | A:1-130 | HUMAN LYSOZYME E102 MUTANT LABELLED WITH 2',3'-EPOXYPROPYL GLYCOSIDE OF N-ACETYLLACTOSAMINE |
1DI3 | A:1-130 | ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME |
1DI4 | A:1-130 | ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME |
1DI5 | A:1-130 | ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME |
1EQ4 | A:1-130 | CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME |
1EQ5 | A:1-130 | CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME |
1EQE | A:1-130 | CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME |
1GAY | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GAZ | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GB0 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GB2 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GB3 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GB5 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GB6 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GB7 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GB8 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GB9 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GBO | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GBW | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GBX | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GBY | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GBZ | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GDW | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS |
1GDX | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS |
1GE0 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS |
1GE1 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS |
1GE2 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS |
1GE3 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS |
1GE4 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS |
1GEV | A:1-130 | BURIED POLAR MUTANT HUMAN LYSOZYME |
1GEZ | A:1-130 | BURIED POLAR MUTANT HUMAN LYSOZYME |
1GF0 | A:1-130 | BURIED POLAR MUTANT HUMAN LYSOZYME |
1GF3 | A:1-130 | BURIED POLAR MUTANT HUMAN LYSOZYME |
1GF4 | A:1-130 | BURIED POLAR MUTANT HUMAN LYSOZYME |
1GF5 | A:1-130 | BURIED POLAR MUTANT HUMAN LYSOZYME |
1GF6 | A:1-130 | BURIED POLAR MUTANT HUMAN LYSOZYME |
1GF7 | A:1-130 | BURIED POLAR MUTANT HUMAN LYSOZYME |
1GF8 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GF9 | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GFA | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GFE | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GFG | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GFH | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GFJ | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GFK | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GFR | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GFT | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GFU | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1GFV | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1HML | A:1-123 | ALPHA_LACTALBUMIN POSSESSES A DISTINCT ZINC BINDING SITE |
1HNL | A:1-130 | CRYSTAL STRUCTURE OF A GLUTATHIONYLATED HUMAN LYSOZYME: A FOLDING INTERMEDIATE MIMIC IN THE FORMATION OF A DISULFIDE BOND |
1I1Z | A:1-130 | MUTANT HUMAN LYSOZYME (Q86D) |
1I20 | A:1-130 | MUTANT HUMAN LYSOZYME (A92D) |
1I22 | A:1-130; B:1-130; C:1-130; D:1-130 | MUTANT HUMAN LYSOZYME (A83K/Q86D/A92D) |
1INU | A:1-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS |
1IOC | A:-3-130 | CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME, EAEA-I56T |
1IP1 | A:1-130 | G37A HUMAN LYSOZYME |
1IP2 | A:1-130 | G48A HUMAN LYSOZYME |
1IP3 | A:1-130; B:501-630 | G68A HUMAN LYSOZYME |
1IP4 | A:1-130 | G72A HUMAN LYSOZYME |
1IP5 | A:1-130 | G105A HUMAN LYSOZYME |
1IP6 | A:1-130 | G127A HUMAN LYSOZYME |
1IP7 | A:1-130; B:501-630 | G129A HUMAN LYSOZYME |
1IWT | A:1-130 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 113K. |
1IWU | A:1-130 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 127K. |
1IWV | A:1-130 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 147K. |
1IWW | A:1-130 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 152K. |
1IWX | A:1-130 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 161K. |
1IWY | A:1-130 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 170K. |
1IWZ | A:1-130 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 178K. |
1IX0 | A:1-130 | I59A-3SS HUMAN LYSOZYME |
1IY3 | A:1-130 | SOLUTION STRUCTURE OF THE HUMAN LYSOZYME AT 4 DEGREE C |
1IY4 | A:1-130 | SOLUTION STRUCTURE OF THE HUMAN LYSOZYME AT 35 DEGREE C |
1JKA | A:1-130 | HUMAN LYSOZYME MUTANT WITH GLU 35 REPLACED BY ASP |
1JKB | A:1-130 | HUMAN LYSOZYME MUTANT WITH GLU 35 REPLACED BY ALA |
1JKC | A:1-130 | HUMAN LYSOZYME MUTANT WITH TRP 109 REPLACED BY PHE |
1JKD | A:1-130 | HUMAN LYSOZYME MUTANT WITH TRP 109 REPLACED BY ALA |
1JSF | A:1-130 | FULL-MATRIX LEAST-SQUARES REFINEMENT OF HUMAN LYSOZYME |
1JWR | A:1-130 | CRYSTAL STRUCTURE OF HUMAN LYSOZYME AT 100 K |
1LAA | A:1-130 | X-RAY STRUCTURE OF GLU 53 HUMAN LYSOZYME |
1LHH | A:1-130 | ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS |
1LHI | A:1-130 | ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS |
1LHJ | A:1-130 | ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS |
1LHK | A:1-130 | ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS |
1LHL | A:1-130 | ROLE OF PROLINE RESIDUES IN HUMAN LYSOZYME STABILITY: A SCANNING CALORIMETRIC STUDY COMBINED WITH X-RAY STRUCTURE ANALYSIS OF PROLINE MUTANTS |
1LHM | A:1-130 | THE CRYSTAL STRUCTURE OF A MUTANT LYSOZYME C77(SLASH)95A WITH INCREASED SECRETION EFFICIENCY IN YEAST |
1LMT | A:1-130 | STRUCTURE OF A CONFORMATIONALLY CONSTRAINED ARG-GLY-ASP SEQUENCE INSERTED INTO HUMAN LYSOZYME |
1LOZ | A:1-130 | AMYLOIDOGENIC VARIANT (I56T) VARIANT OF HUMAN LYSOZYME |
1LYY | A:1-130 | AMYLOIDOGENIC VARIANT (ASP67HIS) OF HUMAN LYSOZYME |
1LZ1 | A:1-130 | REFINEMENT OF HUMAN LYSOZYME AT 1.5 ANGSTROMS RESOLUTION. ANALYSIS OF NON-BONDED AND HYDROGEN-BOND INTERACTIONS |
1LZ4 | A:1-130 | ENTHALPIC DESTABILIZATION OF A MUTANT HUMAN LYSOZYME LACKING A DISULFIDE BRIDGE BETWEEN CYSTEINE-77 AND CYSTEINE-95 |
1LZ5 | A:1-130 | STRUCTURAL AND FUNCTIONAL ANALYSES OF THE ARG-GLY-ASP SEQUENCE INTRODUCED INTO HUMAN LYSOZYME |
1LZ6 | A:1-130 | STRUCTURAL AND FUNCTIONAL ANALYSES OF THE ARG-GLY-ASP SEQUENCE INTRODUCED INTO HUMAN LYSOZYME |
1LZR | A:1-130 | STRUCTURAL CHANGES OF THE ACTIVE SITE CLEFT AND DIFFERENT SACCHARIDE BINDING MODES IN HUMAN LYSOZYME CO-CRYSTALLIZED WITH HEXA-N-ACETYL-CHITOHEXAOSE AT PH 4.0 |
1LZS | A:1-130; B:1-130 | STRUCTURAL CHANGES OF THE ACTIVE SITE CLEFT AND DIFFERENT SACCHARIDE BINDING MODES IN HUMAN LYSOZYME CO-CRYSTALLIZED WITH HEXA-N-ACETYL-CHITOHEXAOSE AT PH 4.0 |
1OUA | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE I56T MUTANT |
1OUB | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V100A MUTANT |
1OUC | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V110A MUTANT |
1OUD | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V121A MUTANT |
1OUE | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V125A MUTANT |
1OUF | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V130A MUTANT |
1OUG | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V2A MUTANT |
1OUH | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V74A MUTANT |
1OUI | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V93A MUTANT |
1OUJ | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V99A MUTANT |
1QSW | A:1-130; B:1-130; C:1-130; D:1-130 | CRYSTAL STRUCTURE ANALYSIS OF A HUMAN LYSOZYME MUTANT W64C C65A |
1RE2 | A:1-130 | HUMAN LYSOZYME LABELLED WITH TWO 2',3'-EPOXYPROPYL BETA-GLYCOSIDE OF N-ACETYLLACTOSAMINE |
1REM | A:1-130 | HUMAN LYSOZYME WITH MAN-B1,4-GLCNAC COVALENTLY ATTACHED TO ASP53 |
1REX | A:1-130 | NATIVE HUMAN LYSOZYME |
1REY | A:1-130 | HUMAN LYSOZYME-N,N'-DIACETYLCHITOBIOSE COMPLEX |
1REZ | A:1-130 | HUMAN LYSOZYME-N-ACETYLLACTOSAMINE COMPLEX |
1TAY | A:1-130 | DISSECTION OF THE FUNCTIONAL ROLE OF STRUCTURAL ELEMENTS OF TYROSINE-63 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME |
1TBY | A:1-130 | DISSECTION OF THE FUNCTIONAL ROLE OF STRUCTURAL ELEMENTS OF TYROSINE-63 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME |
1TCY | A:1-130 | DISSECTION OF THE FUNCTIONAL ROLE OF STRUCTURAL ELEMENTS OF TYROSINE-63 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME |
1TDY | A:1-130 | DISSECTION OF THE FUNCTIONAL ROLE OF STRUCTURAL ELEMENTS OF TYROSINE-63 IN THE CATALYTIC ACTION OF HUMAN LYSOZYME |
1UBZ | A:1-130 | CRYSTAL STRUCTURE OF GLU102-MUTANT HUMAN LYSOZYME DOUBLY LABELED WITH 2',3'-EPOXYPROPYL BETA-GLYCOSIDE OF N-ACETYLLACTOSAMINE |
1W08 | A:1-130 | STRUCTURE OF T70N HUMAN LYSOZYME |
1WQM | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
1WQN | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
1WQO | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
1WQP | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
1WQQ | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
1WQR | A:1-130 | CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
1YAM | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: CALORIMETRIC STUDIES AND X-RAY STRUCTURAL ANALYSIS OF THE FIVE ISOLEUCINE TO VALINE MUTANTS |
1YAN | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: CALORIMETRIC STUDIES AND X-RAY STRUCTURAL ANALYSIS OF THE FIVE ISOLEUCINE TO VALINE MUTANTS |
1YAO | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: CALORIMETRIC STUDIES AND X-RAY STRUCTURAL ANALYSIS OF THE FIVE ISOLEUCINE TO VALINE MUTANTS |
1YAP | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: CALORIMETRIC STUDIES AND X-RAY STRUCTURAL ANALYSIS OF THE FIVE ISOLEUCINE TO VALINE MUTANTS |
1YAQ | A:1-130 | CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: CALORIMETRIC STUDIES AND X-RAY STRUCTURAL ANALYSIS OF THE FIVE ISOLEUCINE TO VALINE MUTANTS |
207L | A:1-130 | MUTANT HUMAN LYSOZYME C77A |
208L | A:1-130 | MUTANT HUMAN LYSOZYME C77A |
2BQA | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQB | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQC | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQD | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQE | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQF | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQG | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQH | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQI | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQJ | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQK | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQL | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQM | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQN | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2BQO | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2EIZ | C:1-129 | CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HW47Y)-HEN LYSOZYME COMPLEX |
2EKS | C:1-129 | CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV-HEN LYSOZYME COMPLEX |
2HEA | A:1-130 | CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY |
2HEB | A:1-130 | CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY |
2HEC | A:1-130 | CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY |
2HED | A:1-130 | CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY |
2HEE | A:1-130 | CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY |
2HEF | A:1-130 | CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY |
2LHM | A:1-130 | CRYSTAL STRUCTURES OF THE APO-AND HOLOMUTANT HUMAN LYSOZYMES WITH AN INTRODUCED CA2+ BINDING SITE |
2MEA | A:1-130; B:1-130 | CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS |
2MEB | A:1-130 | CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS |
2MEC | A:1-130; B:1-130 | CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS |
2MED | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2MEE | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2MEF | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2MEG | A:1-130 | CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS. |
2MEH | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2MEI | A:1-130 | CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME |
2YSS | C:1-129 | CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HQ39KW47Y)-HEN LYSOZYME COMPLEX |
2ZIJ | A:1-130 | CRYSTAL STRUCTURE OF HUMAN LYSOZYME EXPRESSED IN E. COLI. |
2ZIK | A:1-130 | CRYSTAL STRUCTURE OF HUMAN LYSOZYME FROM PICHIA PASTORIS |
2ZIL | A:1-130 | CRYSTAL STRUCTURE OF HUMAN LYSOZYME FROM URINE |
2ZWB | A:1-130 | NEUTRON CRYSTAL STRUCTURE OF WILD TYPE HUMAN LYSOZYME IN D2O |
3FE0 | A:1-130 | X-RAY CRYSTAL STRUCTURE OF WILD TYPE HUMAN LYSOZYME IN D2O |
3LHM | A:1-130 | CRYSTAL STRUCTURES OF THE APO-AND HOLOMUTANT HUMAN LYSOZYMES WITH AN INTRODUCED CA2+ BINDING SITE |